drugset / Trial / NCT00422487
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to collect important information regarding the glucose-lowering efficacy of MBX-2044 and the safety of MBX-2044 (especially weight gain and edema) in diabetics. It will also provide important information about the appropriate doses to be used in subsequent longer-term studies to evaluate the safety and efficacy of MBX-2044 alone and in combination with other anti-diabetic agents.
Timeline
- Start
- 2006-10
- Primary completion
- 2007-08
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MBX-2044 | Unknown | 1.5 mg | Oral |
| Subject | MBX-2044 | Unknown | 4.5 mg | Oral |
| Subject | MBX-2044 | Unknown | 15 mg | Oral |
| Subject | MBX-2044 | Unknown | 30 mg | Oral |
| Subject | MBX-2044 | Unknown | 60 mg | Oral |
| Subject | MBX-2044 | Unknown | 90 mg | Oral |